NAA50 Antikörper (C-Term)
Kurzübersicht für NAA50 Antikörper (C-Term) (ABIN629779)
Target
Alle NAA50 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- C-Term
-
Spezifität
- NAT13 antibody was raised against the C terminal of NAT13
-
Aufreinigung
- Purified
-
Immunogen
- NAT13 antibody was raised using the C terminal of NAT13 corresponding to a region with amino acids AIDFYRKFGFEIIETKKNYYKRIEPADAHVLQKNLKVPSGQNADVQKTDN
-
-
-
-
Applikationshinweise
-
WB: 1.25 µg/mL
Optimal conditions should be determined by the investigator. -
Kommentare
-
NAT13 Blocking Peptide, , is also available for use as a blocking control in assays to test for specificity of this NAT13 antibody
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of NAT13 antibody in PBS
-
Konzentration
- Lot specific
-
Buffer
- PBS
-
Handhabung
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- NAA50 (N(alpha)-Acetyltransferase 50, NatE Catalytic Subunit (NAA50))
-
Andere Bezeichnung
- NAT13
-
Hintergrund
- NAT13 is a probable catalytic component of the ARD1A-NARG1 complex which displays alpha (N-terminal) acetyltransferase activity.
-
Molekulargewicht
- 19 kDa (MW of target protein)
Target
-